Genocea Biosciences Company
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Last Funding Date:
2020-07-22
Last Funding Type:
Post-IPO Equity
Investors Number:
13
Industry:
Atrificial Vectors and Immune Cells
Founded Date:
2006-01-01
Employee Number:
51-100
Total Funding:
470569774
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
$10M to $50M
Funding Status:
IPO